{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:45:25Z","timestamp":1777020325237,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The average age of people living with HIV in Europe is rising and with it the likelihood of entering long-term care. Little is known about the characteristics of people living with HIV in care homes and how their HIV care is delivered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multi-site, cross-sectional descriptive evaluation of care home residents receiving HIV care at seven centres in the UK and Ireland. Data included demographics, HIV history, comorbidities, medication use and HIV service contacts over the preceding 12\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sample included 62 residents with a median age of 61\u00a0years (33\u201392); 81% were male, 56% heterosexual and 60% born in the UK or Ireland. Most (92%) were virally suppressed, having lived with HIV for a median of 21\u00a0years and in care homes for 3\u00a0years. Multimorbidity, frailty and polypharmacy were common. Care home residents represented 0.2% of total service users across all sites. Over 12\u00a0months, participants had a median of four HIV service contacts with two HIV viral load tests. Models of care varied substantially between centres, highlighting inconsistent approaches to supporting this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This service evaluation describes a small, heterogeneous cohort of people living with HIV in long-term care across the UK and Ireland. Participants commonly had complex health needs, and HIV services used varied approaches to deliver care. These descriptive findings provide a foundation for larger studies to examine care models and outcomes for this group to inform future guidance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-025-01389-4","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:14:36Z","timestamp":1766160876000},"page":"1029-1037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How are HIV services in the UK and Ireland managing care home residents living with HIV?"],"prefix":"10.1007","volume":"17","author":[{"given":"Benjamin","family":"Moshy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan J.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maithili","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Boffito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clea","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime H.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Devitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Goffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Mora-Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-0202","authenticated-orcid":false,"given":"Howell T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","volume":"53","author":"EJ Wing","year":"2016","unstructured":"Wing EJ (2016) HIV and aging. Int J Infect Dis 53:61\u201368","journal-title":"Int J Infect Dis"},{"key":"1389_CR2","unstructured":"UK Health Security Agency. HIV testing, PrEP, new HIV diagnoses, and care outcomes for people accessing HIV services: 2022 report. 2022."},{"issue":"11","key":"1389_CR3","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.1016\/S2352-3018(17)30155-8","volume":"4","author":"L Tavoschi","year":"2017","unstructured":"Tavoschi L, Gomes Dias J, Pharris A (2017) New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance data. Lancet HIV 4(11):e514\u2013e521","journal-title":"Lancet HIV"},{"key":"1389_CR4","unstructured":"HIV Commission. How England will end new case of HIV \u2013 final report and recommendations. HIV Commission; 2020 [cited 2020 June 26th]; Available from: https:\/\/www.hivcommission.org.uk\/wp-content\/uploads\/2020\/12\/HIV-Commission-Full-Report_online_final_pages.pdf."},{"issue":"1","key":"1389_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QCO.0000000000000798","volume":"35","author":"HT Jones","year":"2022","unstructured":"Jones HT, Levett T, Barber TJ (2022) Frailty in people living with HIV: an update. Curr Opin Infect Dis 35(1):21\u201330","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"1389_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1758-2652-12-15","volume":"12","author":"L Nyblade","year":"2009","unstructured":"Nyblade L, Stangl A, Weiss E, Ashburn K (2009) Combating HIV stigma in health care settings: what works? J Int AIDS Soc 12(1):15","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"1389_CR7","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/S2352-3018(19)30345-5","volume":"7","author":"M Kall","year":"2020","unstructured":"Kall M, Marcellin F, Harding R, Lazarus JV, Carrieri P (2020) Patient-reported outcomes to enhance person-centred HIV care. Lancet HIV 7(1):e59\u2013e68","journal-title":"Lancet HIV"},{"key":"1389_CR8","unstructured":"OECD, Eurostat and World Health Organization. A System of Health Accounts 2011: Revised edition. OECD EU, World Health Organization, editor. Paris: OECD Publishing; 2017."},{"key":"1389_CR9","doi-asserted-by":"crossref","unstructured":"Schols JMGA, Gordon A. Long-term care: residential and nursing home care; from the past to the future. In: Michel J-P, Beattie BL, Martin FC, Walston J, editors. Oxford Textbook of Geriatric Medicine: Oxford University Press; 2017.","DOI":"10.1093\/med\/9780198701590.003.0037"},{"key":"1389_CR10","unstructured":"Office for National Statistics. Older people living in care homes in 2021 and changes since 2011. ONS; 2023 [cited 2024 July 27th]; Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/ageing\/articles\/olderpeoplelivingincarehomesin2021andchangessince2011\/2023-10-09#cite-this-article."},{"key":"1389_CR11","unstructured":"European AIDS Clinical Society. EACS Guidelines 2023. EACS; 2023 [cited 2024 October 1st]; Available from: https:\/\/www.eacsociety.org\/media\/guidelines-12.0.pdf."},{"issue":"3","key":"1389_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/hiv.13193","volume":"23","author":"HT Jones","year":"2022","unstructured":"Jones HT, Samji A, Cope N, Williams J, Swaden L, Katiyar A et al (2022) What problems associated with ageing are seen in a specialist service for older people living with HIV? HIV Med 23(3):259\u2013267","journal-title":"HIV Med"},{"issue":"4","key":"1389_CR13","first-page":"1","volume":"5","author":"T Levett","year":"2020","unstructured":"Levett T, Roberts J, Adler Z, Wright J, Vera JH, Alford K (2020) Evaluation of a combined hiv and geriatrics clinic for older people living with hiv: The silver clinic in brighton, uk. Geriatr (Switzerland) 5(4):1\u201312","journal-title":"Geriatr (Switzerland)"},{"key":"1389_CR14","unstructured":"UK Health Security Agency. HIV: surveillance, data and management. 2014 [updated 17th February 2025; cited 2025 17th June]; Available from: https:\/\/www.gov.uk\/government\/collections\/hiv-surveillance-data-and-management."},{"issue":"5","key":"1389_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"3","key":"1389_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5770\/cgj.23.463","volume":"23","author":"K Rockwood","year":"2020","unstructured":"Rockwood K, Theou O (2020) Using the clinical frailty scale in allocating scarce health care resources. Can Geriatr J 23(3):210\u2013215","journal-title":"Can Geriatr J"},{"issue":"5","key":"1389_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489\u2013495","journal-title":"CMAJ"},{"issue":"1","key":"1389_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17(1):230","journal-title":"BMC Geriatr"},{"issue":"3","key":"1389_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C (2008) Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 4(3):311\u2013320","journal-title":"Aging Health"},{"issue":"1","key":"1389_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12877-018-0929-6","volume":"18","author":"EK Kiesel","year":"2018","unstructured":"Kiesel EK, Hopf YM, Drey M (2018) An anticholinergic burden score for German prescribers: score development. BMC Geriatr 18(1):239","journal-title":"BMC Geriatr"},{"key":"1389_CR21","unstructured":"King R, Rabino S. ACB Calculator. 2024. p. https:\/\/www.acbcalc.com\/."},{"issue":"2","key":"1389_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/COH.0000000000000595","volume":"15","author":"D De Francesco","year":"2020","unstructured":"De Francesco D, Sabin CA, Reiss P (2020) Multimorbidity patterns in people with HIV. Curr Opin HIV AIDS 15(2):110\u2013117","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"1389_CR23","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jamda.2015.06.025","volume":"16","author":"G Kojima","year":"2015","unstructured":"Kojima G (2015) Prevalence of frailty in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc 16(11):940\u2013945","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1389_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/irdr.2023.01113","volume":"13","author":"Y Deng","year":"2024","unstructured":"Deng Y, Sato N (2024) Global frailty screening tools: review and application of frailty screening tools from 2001 to 2023. Intractable Rare Dis Res 13(1):1\u201311","journal-title":"Intractable Rare Dis Res"},{"issue":"1","key":"1389_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/QAI.0000000000002736","volume":"88","author":"JM McMillan","year":"2021","unstructured":"McMillan JM, Gill MJ, Power C, Fujiwara E, Hogan DB, Rubin LH (2021) Construct and criterion-related validity of the clinical frailty scale in persons with HIV. J Acquir Immune Defic Syndr 88(1):110\u2013116","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1389_CR26","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146\u2013M156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"1389_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","volume":"59","author":"LP Fried","year":"2004","unstructured":"Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59(3):255\u2013263","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"1389_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1017\/S1041610210000608","volume":"22","author":"D Seitz","year":"2010","unstructured":"Seitz D, Purandare N, Conn D (2010) Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr 22(7):1025\u20131039","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"1389_CR29","first-page":"535","volume":"16","author":"N Jokanovic","year":"2015","unstructured":"Jokanovic N, Tan ECK, Dooley MJ, Kirkpatrick CM, Bell JS (2015) Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Direct Assoc 16(6):535","journal-title":"J Am Med Direct Assoc"},{"key":"1389_CR30","doi-asserted-by":"publisher","first-page":"204209862210807","DOI":"10.1177\/20420986221080795","volume":"13","author":"MI Danjuma","year":"2022","unstructured":"Danjuma MI, Adegboye OA, Aboughalia A, Soliman N, Almishal R, Abdul H et al (2022) Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis. Ther Adv Drug Saf 13:20420986221080796","journal-title":"Ther Adv Drug Saf"},{"issue":"6","key":"1389_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/gerona\/glr233","volume":"67A","author":"G Onder","year":"2012","unstructured":"Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P et al (2012) Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 67A(6):698\u2013704","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1389_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002403","author":"M Mazzitelli","year":"2019","unstructured":"Mazzitelli M, Milinkovic A, Pereira B, Palmer J, Tong T, Asboe D et al (2019) Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV. AIDS. https:\/\/doi.org\/10.1097\/QAD.0000000000002403","journal-title":"AIDS"},{"issue":"10","key":"1389_CR33","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.jamda.2021.05.039","volume":"22","author":"L Oudewortel","year":"2021","unstructured":"Oudewortel L, van der Roest HG, Onder G, Wijnen VJM, Liperoti R, Denkinger M et al (2021) The association of anticholinergic drugs and delirium in nursing home patients with dementia: results from the SHELTER study. J Am Med Direct Assoc 22(10):2087\u20132092","journal-title":"J Am Med Direct Assoc"},{"key":"1389_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002768","author":"SA Cooley","year":"2021","unstructured":"Cooley SA, Paul RH, Strain JF, Boerwinkle A, Kilgore C, Ances BM (2021) Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV. AIDS. https:\/\/doi.org\/10.1097\/QAD.0000000000002768","journal-title":"AIDS"},{"key":"1389_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003966","author":"HU Michael","year":"2024","unstructured":"Michael HU, Brouillette M-J, Tamblyn R, Fellows LK, Mayo NE (2024) Cognitive impact of anticholinergic and sedative burden in people with HIV. AIDS. https:\/\/doi.org\/10.1097\/QAD.0000000000003966","journal-title":"AIDS"},{"issue":"3","key":"1389_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-019-02795-x","volume":"76","author":"S Ali","year":"2020","unstructured":"Ali S, Peterson GM, Bereznicki LR, Salahudeen MS (2020) Association between anticholinergic drug burden and mortality in older people: a systematic review. Europ J Clin Pharmacol 76(3):319\u2013335","journal-title":"Europ J Clin Pharmacol"},{"issue":"12","key":"1389_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/hiv.13532","volume":"24","author":"J Doctor","year":"2023","unstructured":"Doctor J, Winston A, Vera JH, Post FA, Boffito M, Mallon PWG et al (2023) Anticholinergic medications associated with falls and frailty in people with HIV. HIV Med 24(12):1198\u20131209","journal-title":"HIV Med"},{"key":"1389_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad176","author":"E Braithwaite","year":"2023","unstructured":"Braithwaite E, Todd OM, Atkin A, Hulatt R, Tadrous R, Alldred DP et al (2023) Interventions for reducing anticholinergic medication burden in older adults\u2014a systematic review and meta-analysis. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afad176","journal-title":"Age Ageing"},{"key":"1389_CR39","first-page":"4","volume":"21","author":"LA Hill","year":"2019","unstructured":"Hill LA, Ballard C, Cachay ER (2019) The role of the clinical pharmacist in the management of people living with HIV in the modern antiretroviral era. AIDS Rev 21:4","journal-title":"AIDS Rev"},{"issue":"2","key":"1389_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11904-021-00543-4","volume":"18","author":"JZ Budak","year":"2021","unstructured":"Budak JZ, Scott JD, Dhanireddy S, Wood BR (2021) The impact of COVID-19 on HIV care provided via telemedicine\u2014past, present, and future. Curr HIV\/AIDS Rep 18(2):98\u2013104","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1389_CR41","unstructured":"British HIV Association. BHIVA guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals (2019 interim update). BHIVA; 2019 [cited 2024 October 14th]; Available from: https:\/\/www.bhiva.org\/file\/DqZbRxfzlYtLg\/Monitoring-Guidelines.pdf."},{"issue":"S1","key":"1389_CR42","first-page":"9","volume":"25","author":"L Riddell","year":"2024","unstructured":"Riddell L (2024) What if we see you in clinic once a year? Triple benefits of changing the HIV care pathway to align with other chronic diseases. HIV Med 25(S1):9\u201310","journal-title":"HIV Med"},{"issue":"4","key":"1389_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.14283\/jfa.2023.23","volume":"12","author":"LF Tan","year":"2023","unstructured":"Tan LF, Teng J, Chew ZJ, Choong A, Hong L, Aroos R et al (2023) Geriatric services hub: a collaborative frailty management model between the hospital and community providers. J Frailty Aging 12(4):316\u2013321","journal-title":"J Frailty Aging"},{"issue":"1","key":"1389_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12913-021-07407-y","volume":"22","author":"A Steel","year":"2022","unstructured":"Steel A, Hopwood H, Goodwin E, Sampson EL (2022) Multidisciplinary residential home intervention to improve outcomes for frail residents. BMC Health Serv Res 22(1):58","journal-title":"BMC Health Serv Res"},{"issue":"S3","key":"1389_CR45","volume":"15","author":"J Garley","year":"2014","unstructured":"Garley J, Bignell C, das Nair R (2014) A qualitative survey of attitudes towards HIV amongproviders of community care. HIV Med 15(S3):45","journal-title":"HIV Med"},{"issue":"4","key":"1389_CR46","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s41999-022-00642-4","volume":"13","author":"HT Jones","year":"2022","unstructured":"Jones HT, Barber TJ (2022) How do geriatricians feel about managing older people living with HIV? A scoping review. Eur Geriatr Med 13(4):987\u2013997","journal-title":"Eur Geriatr Med"},{"issue":"574","key":"1389_CR47","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3399\/bjgp10X501840","volume":"60","author":"H Defty","year":"2010","unstructured":"Defty H, Kennedy M, Smith H, Perry N, Fisher M (2010) GPs\u2019 perceived barriers to their involvement in caring for patients with HIV: a questionnaire-based study. Br J Gen Pract 60(574):348\u2013351","journal-title":"Br J Gen Pract"},{"issue":"2","key":"1389_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0277-9536(99)00278-6","volume":"50","author":"R Petchey","year":"2000","unstructured":"Petchey R, Farnsworth B, Williams J (2000) The last resort would be to go to the GP\u2019. Understanding the perceptions and use of general practitioner services among people with HIV\/AIDS. Soc Sci Med (1982) 50(2):233\u2013245","journal-title":"Soc Sci Med (1982)"},{"key":"1389_CR49","first-page":"91","volume":"2015","author":"L Hawkins","year":"2015","unstructured":"Hawkins L, Cassell J (2015) What is the role of general practice and the potential barriers in providing shared care for people living with HIV: a systematic review. Sex Trans Infect 2015:91","journal-title":"Sex Trans Infect"},{"key":"1389_CR50","doi-asserted-by":"crossref","unstructured":"Brown MT, Bussell JK, editors. Medication adherence: WHO cares? Mayo clinic proceedings; 2011: Elsevier.","DOI":"10.4016\/27949.01"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01389-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:02:19Z","timestamp":1777017739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01389-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01389-4","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TJB has received speaker fees, conference support and advisory board honoraria from Gilead Sciences LTD., ViiV, Roche, MSD and NovoNordisk. ED has received speaker fees and conference support from Gilead Sciences LTD. and ViiV. MB has received speaker and advisor fees and\/or research grants (to the Organisation) from Gilead Sciences LTD., ViiV, Roche, MSD, GSK, Pfizer, Novavax, Valneva, Moderna, Mylan, Cipla, Janssen, Atea and AZ. JHV has received speaker fees from Gilead Sciences LTD., ViiV and MSD. BMP has received speaker fees from ViiV and MSD. LH has received speaker fees from Gilead Sciences LTD. and ViiV. HTJ has received speaker fees from ViiV. BM, MV, CT, GF, AG, ML, CG and LH have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Due to this being a service evaluation, ethical approval was not required as per the Health Research Authority.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}